ArticleBlood advances2025
Uncovering the role of the Hsp40 family member cysteine string protein-α in mouse platelets.
Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
abstractPlatelets modulate vascular microenvironments via the release of cargo molecules. Granule secretion is modulated by proteins called soluble N-ethylmaleimide sensitive factor attachment protein receptors (SNAREs). Secretion is complex and regulated by several protein-protein interactions; however, not all are characterized in platelets. We have identified cysteine string protein-α (CSPα; also known as, DNAJC5 or CLN4) as required for platelet secretion. CSPα is the only member from the CSP family present in platelets and has been proposed as a chaperone for the SNAP-23/25 t (Qb,c) SNAREs. To address CSPα's role, we analyzed platelets from CSPα-/- mice. The loss of CSPα significantly affected dense- and α-granule release with minimal effects on lysosomal secretion. Consistent with the secretion defects, in vivo and ex vivo assays showed that loss of CSPα caused significant bleeding and attenuated thrombosis under flow. Interestingly, loss of CSPα caused a reduction in glycoprotein VI (GPVI) levels and reduced αIIbβ3 activation, especially in response to GPVI-specific agonists. Deletion of CSPα did not affect proteins in the platelet secretory machinery, for example, the SNAP-23/25 proteins. Subcellular fractionation studies showed that CSPα, which is reported to be acylated, was present on membranes but not in lipid rafts. Immunofluorescence studies showed CSPα colocalized with α and lysosomal granule markers. CSPα-/- mice had reduced red blood cell, leukocyte, and megakaryocyte numbers, suggesting effects on bone marrow progenitor cells. Simultaneously, we detected increased collagen I deposition, but no fibrosis in the marrow of CSPα-/- mice. These results identify CSPα as another element of the platelet secretory machinery that significantly contributes to thrombosis and hemostasis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.